Es particularmente beneficioso para las personas que experimentan sntomas como fatiga, niebla cerebral, problemas digestivos, y la inflamacin crnica
Recommended bY Specialists: General Physicians It is preferred to treat the disease associated with the management of generalized weakness, fatigue, and nutritional deficiencies
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
Humidity: Store in a dry environment to reduce risk of packaging compromise
The body naturally excretes any excess through urine, which helps regulate its levels efficiently
10.1007/978-3-211-85578-2_85 58 GrayN